VYNE Therapeutics
VYNE
#9889
Rank
S$31.92 M
Marketcap
$2.10
Share price
-6.59%
Change (1 day)
-45.19%
Change (1 year)

VYNE Therapeutics (VYNE) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : S$19.93 Million

According to VYNE Therapeutics's latest financial reports the company's total liabilities are S$19.93 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

VYNE Therapeutics - Total liabilities on balance sheet (from 2016 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$20.14 M70.41%
2023-12-31S$11.82 M-7.73%
2022-12-31S$12.81 M-48.53%
2021-12-31S$24.88 M-66.55%
2020-12-31S$74.41 M417.74%
2019-12-31S$14.37 M10.15%
2018-12-31S$13.04 M-92.13%
2017-12-31S$0.16 B60.15%
2016-12-31S$0.10 B22.25%
2015-12-31S$84.64 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
S$41.73 M 109.33%๐Ÿ‡บ๐Ÿ‡ธ USA